Li-xia Yang
Kunming, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Serum potassium and high-altitude coronary microvascular disease: a propensity score matched analysis revealing a linear dose-response relationship.
Journal: Frontiers in pharmacology
Published: March 10, 2026
Inverse association between pre-high-altitude potassium levels and coronary microvascular disease at high altitude: a case-control study.
Journal: Frontiers in pharmacology
Published: July 03, 2025
Differential expression of platelet CD147 in moderate altitude conditions: implications for coronary plaque stability assessment.
Journal: Frontiers in cardiovascular medicine
Published: May 01, 2025
Integrating genomic profiling to clinical data: assessing the impact of CD147 expression on plaque stability.
Journal: Frontiers in cardiovascular medicine
Published: April 30, 2024
Nomogram models for predicting myocardial ischemia under high altitude exposure: a cohort study.
Journal: Scientific reports
Published: January 23, 2024
Machine learning-based prediction model for myocardial ischemia under high altitude exposure: a cohort study.
Journal: Scientific reports
Published: September 15, 2023
Yunnanterpene G, a spiro-triterpene from the roots of Cimicifuga foetida, downregulates the expression of CD147 and MMPs in PMA differentiated THP-1 cells.
Journal: RSC advances
Published: March 04, 2018
MicroRNA-99a inhibits insulin-induced proliferation, migration, dedifferentiation, and rapamycin resistance of vascular smooth muscle cells by inhibiting insulin-like growth factor-1 receptor and mammalian target of rapamycin.
Journal: Biochemical and biophysical research communications
Published: March 08, 2017
Five-year outcomes of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with biodegradable polymer-coated sirolimus-eluting stents: Insights from the CREATE trial.
Journal: Journal of cardiology
Published: December 03, 2015
Atorvastatin attenuates plaque vulnerability by downregulation of EMMPRIN expression via COX-2/PGE2 pathway.
Journal: Experimental and therapeutic medicine
Published: July 14, 2015
Changes in levels of angiotensin II and its receptors in a model of inverted stress-induced cardiomyopathy.
Journal: European journal of medical research
Published: April 29, 2014
Last Updated: 09/26/2026